Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen

Transplantation

Volumn 68, Issue 7, 1999, Pages 1029-1036

  Valujskikh, Anna ^b   Matesic, Damir ^b   Heeger, Peter S ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MINOR HISTOCOMPATIBILITY ANTIGEN; TRANSPLANTATION ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE;

ANIMALS; BETA-GALACTOSIDASE; CYTOKINES; EPITOPES; FEMALE; GRAFT REJECTION; IMMUNE TOLERANCE; INTERFERON TYPE II; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MINOR HISTOCOMPATIBILITY ANTIGENS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TH1 CELLS; TRANSGENES;

EID: 0033570114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00022     Document Type: Article

References (25)

1. Simpson E. Minor transplantation antigens. Animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions. Transplantation 1998; 65: 611.
2. Perreault C, Roy D, Fortin C. Immunodominant minor histocompatibility antigens: the major ones. Immunol Today 1998; 19: 69.
3. Berger M, Wettstein P, Korngold R. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Transplantation 1994; 57: 1095.
4. Murphy G, Whitaker D, Sprent J, Korngold R. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either cd4+ or cd8+ effector cells. Am J Pathol 1991; 138: 983.
5. Bevan M. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol 1976; 117: 2233.
6. Hill A, Mullbacher A, Blanden R. IrI Genes, peripheral crosstolerance and immunodominance in MHC class I-restricted T-cell responses: an old quagmire revisited. Immunol Rev 1993; 133: 75.
7. Roopenian D. What are minor histocompatibility loci? A new-look at an old question. Immunol Today 1992; 13: 7.
8. Mendoza L, Paz P, Zuberi A, Christianson G, Roopenian D, Shastri N. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 1997; 7: 461.
9. Speiser D, Zurcher T, Ramseier H, et al. Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc Natl Acad Sci USA1990; 87: 2021.
10. Wang W, Meadows L, den Haan J, et al. Human H-Y: A Malespecific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 1588.
11. Rammensee H, Schild H, Theopold U. Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intra-cellular, membrane-associated or secreted forms of beta-galactosidase. Immunogenetics 1989; 30: 296.
12. Rotzschke O, Falk K, Wallny H, Faath S, Rammensee H. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990; 249: 283.
13. Scott D, Ehrmann I, Ellis P, et al. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 1995; 376: 695.
14. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen tot identy and nutate developmental genes in mice. Genes Dev 1991; 5: 1513.
15. b-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for self antigens. Methods 1997; 12: 117.
16. Valujskikh A, Matesic D, Gilliam A, Anthony D, Haqqi T, Heeger P. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998; 101: 1398.
17. Matzinger P. The JAM test. A simple assay for DNA fragmentation. J Immunol Methods 1991; 145: 185.
18. Matesic D, Lehmann P, Heeger P. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65: 906.
19. Desquenne-Clark L, Kimura H, Silvers W. Priming and crosspriming for H-Y in female mice. Transplantation 1992; 54: 916.
20. Oukka M, Galou M, Belkaid Y, et al. Major histocompatibiity complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection. Eur J Immunol 1997; 27: 3499.
21. Lehmann P, Matesic D, Benichou G, Heeger P. Induction of T helper 2 immunity to an immunodominant allopeptide. Transplantation 1997; 64: 292.
22. Saleem S, Konieczny B, Lowry R, Baddoura F, Lakkis F. Acute rejection of vascularized heart allografts in the absence of IFNgamma. J Immunol 1996; 62: 1908.
23. Matesic D, Valujskikh A, Pearlman E, Higgins A, Gilliam A, Heeger P. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. J Immunol 1998; 161: 5236.
24. Foster S, Wood K, Morris P. The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. Transplantation 1992; 53: 1322.
25. Liblau R, Tisch R, Shokat K, et al. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc Natl Acad Sci USA 1996; 93; 3031.